Spectrum Pharma (SPPI) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts SPPI Hot Sheet
Price: $1.03 --0%
EPS Growth %: +100.0%
Financial Fact:
Selling, general and administrative: 19.47M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +100.0%
Financial Fact:
Selling, general and administrative: 19.47M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $27.58 million.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
